1Ottensooser F,Mellone O,Biancalana A. Fatal transfusion reaction due to the Kell factor[J].Blood,1953.1029-1033.
2Olerup O,Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours:an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation[J].Tissue Antigens,1992.225-235.
3He YL,Gao HH,Ye LY. Multiplex polymerase chain reaction with DNA pooling:a cost-effective strategy of genotyping rare blood types[J].Transfusion Medicine,2013.42-47.
4Prager M. Molecular genetic blood group typing by the use of PCR-SSP technique[J].Transfusion,2007.54S-59S.
5Wagner FF,Bittner R,Petershofen EK. Cost-efficient sequence-specific priming-polymerase chain reaction screening for blood donors with rare phenotypes[J].Transfusion,2008.1169-1173.
6Coombs RRA,Mourant AE,Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease[J].The Lancet,1946.264-266.
7Grant SR,Kilby MD,Meer L. The outcome of pregnancy in Kell alloimmunisation[J].BJOG: An International Journal of Obstetrics & Gynaecology,2000.481-485.
8Ferguson SJ,Boyce F,Blajchman MA. Anti-Ytb in pregnancy[J].Transfusion,1979.581-582.
9Telen MJ,Rosse WF,Parker CJ. Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins[J].Blood,1900.1404-1407.
10Mohandas K,Spivack M,Delehanty CL. Management of patients with anti-Cartwright (Yta)[J].Transfusion,1985.381-384.
